Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | ELANE | P08246 | 2/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 3/20 | 0.42 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1790037 | 0.93 | GAA (0.58) | GAAPKMALDH1A1ELANEAPP | |
| SCHEMBL51856 | 0.93 | GAA (0.58) | GAAPKMALDH1A1ELANEAPP | |
| SCHEMBL1793890 | 0.91 | PKM (0.63) | GAAPKMALDH1A1ELANENPSR1 | |
| SCHEMBL50786 | 0.90 | PKM (0.58) | GAAPKMALDH1A1ELANENPSR1 | |
| SCHEMBL6285323 | 0.88 | GAA (0.59) | GAAPKMALDH1A1ELANENPSR1 | |
| SCHEMBL6333881 | 0.88 | GAA (0.59) | GAAPKMALDH1A1ELANENPSR1 | |
| SCHEMBL10899984 | 0.87 | GAA (0.56) | GAAPKMALDH1A1ELANEAPP | |
| SCHEMBL15127428 | 0.87 | GAA (0.51) | GAAPKMALDH1A1ELANEAPP | |
| SCHEMBL51746 | 0.86 | GAA (0.61) | GAAPKMALDH1A1ELANENPSR1 | |
| SCHEMBL6288097 | 0.86 | GAA (0.61) | GAAPKMALDH1A1ELANENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563468-B2 | Color developing composition containing molecular compound, and recording material | NIPPON SODA CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| EP-2332733-B1 | COLOR DEVELOPING COMPOSITION CONTAINING MOLECULAR COMPOUND, AND RECORDING MATERIAL | NIPPON SODA CO (JP) | 2012-11-28 | — | — | EP | disclosed |
| EP-2332733-A1 | COLOR DEVELOPING COMPOSITION CONTAINING MOLECULAR COMPOUND, AND RECORDING MATERIAL | Nippon Soda Co., Ltd. (JP) | 2011-06-15 | — | — | EP | disclosed |
| US-20110120345-A1 | COLOR DEVELOPING COMPOSITION CONTAINING MOLECULAR COMPOUND, AND RECORDING MATERIAL | NIPPON SODA CO., LTD. (JP) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110120345-A1 | COLOR DEVELOPING COMPOSITION CONTAINING MOLECULAR COMPOUND, AND RECORDING MATERIAL | HBG1, HBG2, CYC1 | GAA 3458/4885PKM 2273/4885ALDH1A1 1621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.